Serina Therapeutics, Inc.SERNYSE
Loading
Revenue ContractionContracting
Percentile Rank22
3Y CAGR-38.6%
5Y CAGR+16.5%
Year-over-Year Change
Total revenue from sales of goods and services
3Y CAGR
-38.6%/yr
vs -22.6%/yr prior
5Y CAGR
+16.5%/yr
Recent deceleration
Acceleration
-15.9pp
Decelerating
Percentile
P22
Within normal range
vs 5Y Ago
2.1x
Strong expansion
Streak
1 yr
Consecutive growthContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $116000.00 | +107.1% |
| 2024 | $56000.00 | -98.2% |
| 2023 | $3.15M | +530.6% |
| 2022 | $500000.00 | -83.5% |
| 2021 | $3.04M | +5528.1% |
| 2020 | $54000.00 | -96.9% |
| 2019 | $1.73M | +23.8% |
| 2018 | $1.40M | -0.6% |
| 2017 | $1.40M | -15.7% |
| 2016 | $1.67M | - |